RWEpi (Real World Cancer Epidemiology Research Group)

Research Group

The Real World Epidemiology (RWEpi) research group is a multidisciplinary team including epidemiologists, statisticians, clinicians, data scientists, and pre- and post-doctoral researchers with extensive experience in analysing and interpreting large, real-world data from different countries. Our main goal is to generate reliable scientific evidence by using routinely collected data from different settings of the healthcare system. We are currently involved in a number of national and international studies focused on the understanding of the natural history and determinants of multiple diseases/conditions (e.g. cancer, COVID-19, obesity, mental health, etc), the safety and effectiveness of new medicines and vaccines, and the implementation of methodological approaches to analyse and evaluate the quality of real-world data. We are also particularly interested in population subgroups such as the pediatric and pregnant women populations, being recently able to link a large cohort of mother and child electronic healthcare records from primary care in Catalonia; as well as understanding health inequalities, and the role of lifestyle and urban environmental exposures on health.

The group participates in the following projects

PI: Duarte Salles, Talita. Optimal treatment for patients with solid tumours in Europe through Artificial intelligence. Funding: STICHTING EUROPEAN UROLOGICAL FOUNDATION . Duration: 2021 - 2027

PI: Villalobos Martínez, Felipe. Post-Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID -19) Vaccine. Funding: Fondazione Penta ONLUS. Duration: 2021 - 2024

PI: Vila Corcoles, Angel. Efectividad clínica e impacto de la vacunación antineumocócica conjugada (VNC13) y/o polisacárida (VNP23) en adultos con distintas condiciones de riesgo: estudio de cohortes de base poblacional post introducción de la vacunación infantil universal con VNC13. Funding: Instituto de Salud Carlos III. Duration: 2021 - 2023

PI: Duarte Salles, Talita. Natural history of coagulopathy and use of anti-thrombotic agents in COVID-19 patients. Funding: ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC). Duration: 2021 - 2023

PI: Duarte Salles, Talita. Drug Utilization Study (DUS) and Post Authorization Safety Study (PASS) on the fixed combination tramadol-dexketoprofen (DKP-TRAM). Funding: SIMG SERVICE CONGRESS AND EDUCATION S.R.L . Duration: 2021 - 2023

PI: Duarte Salles, Talita. The descriptive epidemiology of Adverse Events of Special Interest for COVID-19 and other vaccines and after seasonal influenza and COVID-19 disease in SIDIAP. Funding: IDIAP Jordi Gol. Duration: 2021 - 2023

PI: Duarte Salles, Talita. Examining the etiology of early-onset colorectal cancer (EOCRC) in the SIDIAP database - research protocol. Funding: International Agency for Research on Cancer (IARC). Duration: 2021 - 2023

PI: Duarte Salles, Talita. Associations between playspaces and childhood overweight and obesity in Barcelona. Funding: IDIAP Jordi Gol. Duration: 2021 - 2023

PI: Lopez Bermejo, Abel. Associació entre la tensió arterial en embarassades sanes i el risc de sobrepès/obesitat i tensió arterial alta en la descendència: Estudi de cohort longitudinal en 500.000 parelles mare-fill de Catalunya. Funding: ICS - Institut Català de la Salut. Duration: 2021 - 2023

PI: Duarte Salles, Talita. UNravelling COVID-19 through rEal-woRld data (UNCOVER). Funding: IDIAP Jordi Gol. Duration: 2021 - 2023

PI: Duarte Salles, Talita. Association between thrombosis with thrombocytopenia syndrome (TTS) or thromboembolic events, and COVID-19 vaccines. Funding: ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC). Duration: 2021 - 2023

PI: Villalobos Martínez, Felipe. Rapid Safety Assessment of SARS-CoV-2 vaccines in EU Member States using electronic health care datasources (WP3). Funding: Vaccine Monitoring Collaboration for Europe (VAC4EU). Duration: 2021 - 2023

PI: Villalobos Martínez, Felipe. Post-Authorization Active Surveillance Safety Study Using Secondary Data to Monitor Real-World Safety of Spikevax in Europe. Funding: Julius Clinical Research B.V.. Duration: 2021 - 2023

PI: Duarte Salles, Talita. Real world trends in surgical procedures- an international network study. Funding: University of Oxford. Duration: 2021 - 2023

PI: Villalobos Martínez, Felipe. Cohort Event Monitoring of safety of COVID-19 vaccines in special populations (pregnant and lactating women, children and adolescents, immunocompromised, people with history of allergy, people with prior SARS-CoV-2 infection) (WP1). Funding: Vaccine Monitoring Collaboration for Europe (VAC4EU). Duration: 2021 - 2023

PI: Villalobos Martínez, Felipe. Monitoring safety of Spikevax in pregnancy: an observational study using routinely collected health data in five European countries. Funding: Julius Clinical Research B.V.. Duration: 2021 - 2023

PI: Duarte Salles, Talita. Drug utilisation studies using data mapped to the OMOP Common Data Model: a proof of concept study assessing respiratory drug use in patients with asthma or COPD.. Funding: ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC). Duration: 2021 - 2023

PI: Duarte Salles, Talita. Research Protocol for an Observational Health Data Analysis to Assess the Long-term Outcomes of Prostate Cancer Patients Undergoing Non-Interventional Management (i.e., Watchful Waiting) and the Impact of Comorbidities and Life Expectancy - PIONEER IMI's "Big Data for Better Outcomes" program. Funding: STICHTING EUROPEAN UROLOGICAL FOUNDATION . Duration: 2021 - 2023

PI: Villalobos Martínez, Felipe. An Observational Post-Authorization Safety Study to Assess the Safety of Ad26.COV2.S Using European Healthcare Data through VAC4EU. Funding: Team-It Research S.L. Duration: 2021 - 2023

PI: Duarte Salles, Talita. Obesity and cancer risk and survival: the role of co-morbidities. Funding: International Agency for Research on Cancer (IARC). Duration: 2020 - 2023

PI: Duarte Salles, Talita. Risk of mental and behavioral disorders in relation to availability of green spaces. Funding: IDIAP Jordi Gol. Duration: 2021 - 2022

PI: Duarte Salles, Talita. Systemic glucocorticoids in the treatment of COVID-19 and risks of adverse outcomes in COVID-19 patients in the primary and secondary care setting. Funding: IQVIA Solutions BV. Duration: 2021 - 2022

PI: Duarte Salles, Talita. Impact of EU label changes fluoroquinolone containing medicinal products for systemic and inhalation use: post-referral prescribing trends (IQVIA). Funding: IQVIA Solutions BV. Duration: 2021 - 2022

PI: Basora Gallisà, Josep. Projecte validació de mascaretes FFP2-CSIC. Funding: Gomà-Camps, S.A.U.. Duration: 2021 - 2022

PI: Berenguera Ossó, Anna. Mechanisms of long-COVID and effect of COVID-19 vaccination on long-COVID. Funding: Fundación Privada Instituto de Salud Global Barcelona (ISGlobal). Duration: 2021 - 2022

PI: Sala Serra, Maria. CONCEPT-SURBCAN: uso de datos del mundo real para estudiar la efectividad y la eficiencia de la atención a supervivientes de cáncer de mama de larga duración. Funding: Instituto de Salud Carlos III. Duration: 2020 - 2022

PI: Duarte Salles, Talita. Musculoskeletal adverse outcomes after treatment with aromatase inhibitors for breast cancer: a SIDIAP-OHDSI based cohort study. Funding: University of Oxford. Duration: 2020 - 2022

PI: Duarte Salles, Talita. Use of hydrochlorothiazide and risk of skin cancer. Funding: IDIAP Jordi Gol. Duration: 2020 - 2022

PI: Duarte Salles, Talita. Residential outdoor play spaces and children's diagnosed mental and behavioural disorders: the role of individual and area-level socio economic characteristics. Funding: IDIAP Jordi Gol. Duration: 2020 - 2022

PI: Aragón Pérez, María. vACCine covid-19 monitoring readinESS (ACCESS). Funding: UMC Utrecht (University Medical Center Utrecht). Duration: 2020 - 2022

PI: Duarte Salles, Talita. Body size and risk of development of 22 major cancers: Data from the Information System for the Development of Research in Primary Care collected on 6 million Catalans. Funding: WCRF NL Stichting Wereld Kanker Onderzoek Fonds. Duration: 2018 - 2022

PI: Puente Baliarda, Diana. Síndrome metabólico y riesgo de cáncer: estudio caso-control con datos del Sistema de Información para el Desarrollo de la Investigación en Atención Primaria (SIDIAP) en Cataluña. Funding: Instituto de Salud Carlos III. Duration: 2018 - 2022

PI: Medina Perucha, Laura. El diagnóstico tardío de la endometriosis en Cataluña: un estudio participativo de metodología mixta. Funding: Associació d'Afectades d'Endometriosi de Catalunya. Duration: 2021 - 2021

PI: Duarte Salles, Talita. The Information System for Research in Primary Care: EHDEN Data Partner. Funding: ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC). Duration: 2020 - 2021

PI: Duarte Salles, Talita. Ranitidine and other histamine-H2-receptor antagonists - Drug Utilisation Study. Funding: ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC). Duration: 2020 - 2021

PI: Duarte Salles, Talita. OHDSI: Comparative risk of the incident cancer between histamine-2 receptor antagonists. Funding: Kandong Sacred Heart Hospital. Duration: 2020 - 2021

PI: Duarte Salles, Talita. Exploring the influence of cardiovascular disease risk at breast cancer diagnosis on systemic chemotherapy prescribing: A cross sectional study using Catalan databases. Funding: IDIAP Jordi Gol. Duration: 2019 - 2021

PI: Duarte Salles, Talita. Knee and hip osteoarthritis and risk of cancer - register based epidemiology. Funding: IDIAP Jordi Gol. Duration: 2019 - 2021

PI: Reyes Reyes, Carlen. Estimating Short-Term and Long-Term Direct Economic Burden Associated with Osteoporotic Fracture. Funding: IQVIA LTD. Duration: 2019 - 2021

PI: Duarte Salles, Talita. The Information System for Research in Primary Care: EHDEN Data Partner. Funding: ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM (EMC). Duration: 2019 - 2021

Group publications

Berenguera A, Jacques-Aviñó C, Medina-Perucha L, Puente D. Long term consequences of COVID-19. Eur J Intern Med. 2021 10; 92:34-35. doi:10.1016/j.ejim.2021.08.022. Epub 2021 Sep 02. pmc:PMC8410511. PMID:34509350. IF: 4,487.

Burn E, Tebé C, Fernandez-Bertolin S, Aragon M, Recalde M, Roel E, Prats-Uribe A, Prieto-Alhambra D, Duarte-Salles T. The natural history of symptomatic COVID-19 during the first wave in Catalonia. Nat Commun. 2021 02; 12(1):777. doi:10.1038/s41467-021-21100-y. Epub 2021 Feb 03. pmc:PMC7858639. PMID:33536436. IF: 14,919.

de Bont J, Bennett M, León-Muñoz LM, Duarte-Salles T. The prevalence and incidence rate of overweight and obesity among 2.5 million children and adolescents in Spain. Rev Esp Cardiol (Engl Ed). 2021 Aug; doi:10.1016/j.rec.2021.07.002. Epub 2021 Aug 09. PMID:34384717. IF: .

de Bont J, Díaz Y, de Castro M, Cirach M, Basagaña X, Nieuwenhuijsen M, Duarte-Salles T, Vrijheid M. Ambient air pollution and the development of overweight and obesity in children: a large longitudinal study. Int J Obes (Lond). 2021 05; 45(5):1124-1132. doi:10.1038/s41366-021-00783-9. Epub 2021 Feb 24. PMID:33627774. IF: 5,095.

de Bont J, Márquez S, Fernández-Barrés S, Warembourg C, Koch S, Persavento C, Fochs S, Pey N, de Castro M, Fossati S, Nieuwenhuijsen M, Basagaña X, Casas M, Duarte-Salles T, Vrijheid M. Urban environment and obesity and weight-related behaviours in primary school children. Environ Int. 2021 10; 155:106700. doi:10.1016/j.envint.2021.106700. Epub 2021 Jun 15. PMID:34144474. IF: 9,621.

Duarte-Salles T, Prieto-Alhambra D. Heterologous vaccine regimens against COVID-19. Lancet. 2021 07; 398(10295):94-95. doi:10.1016/S0140-6736(21)01442-2. Epub 2021 Jun 25. pmc:PMC8233006. PMID:34181881. IF: 79,321.

Duarte-Salles T, Vizcaya D, Pistillo A, Casajust P, Sena AG, Lai LYH, Prats-Uribe A, Ahmed WU, Alshammari TM, Alghoul H, Alser O, Burn E, You SC, Areia C, Blacketer C, DuVall S, Falconer T, Fernandez-Bertolin S, Fortin S, Golozar A, Gong M, Tan EH, Huser V, Iveli P, Morales DR, Nyberg F, Posada JD, Recalde M, Roel E, Schilling LM, Shah NH, Shah K, Suchard MA, Zhang L, Zhang Y, Williams AE, Reich CG, Hripcsak G, Rijnbeek P, Ryan P, Kostka K, Prieto-Alhambra D. Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience. Pediatrics. 2021 09; 148(3). doi:10.1542/peds.2020-042929. Epub 2021 May 28. PMID:34049958. IF: 7,124.

Elena Roel, Andrea Pistillo, Martina Recalde, Anthony G. Sena, Sergio Fernández-Bertolín, María Aragón, Diana Puente, Waheed-Ul-Rahman Ahmed, Heba Alghoul, Osaid Alser, Thamir M. Alshammari, Carlos Areia, Clair Blacketer, William Carter, Paula Casajust, Aedin C. Culhane, Dalia Dawoud, Frank DeFalco, Scott L. Duvall, Thomas Falconer, Asieh Golozar, Mengchun Gong, Laura Hester, George Hripcsak, Eng Hooi Tan, Hokyun Jeon, Jitendra Jonnagaddala, Lana Y.H. Lai, Kristine E. Lynch, Michael E. Matheny, Daniel R. Morales, Karthik Natarajan, Fredrik Nyberg, Anna Ostropolets, José D. Posada, Albert Prats-Uribe, Christian G. Reich, Donna Rivera, Lisa M. Schilling, Isabelle Soerjomataram, Karishma Shah, Nigam Shah, Yang Shen, Matthew Spotniz, Vignesh Subbian, Marc A. Suchard, Annalisa Trama, Lin Zhang, Ying Zhang, Patrick Ryan, Daniel Prieto-Alhambra, Kristin Kostka, Talita Duarte-Salles. Characteristics and outcomes of 118,155 COVID-19 individuals with a history of cancer in the United States and Spain. medRxiv 2021.01.12.21249672; doi: https://doi.org/10.1101/2021.01.12.21249672 IF: .

Jansana A, Poblador-Plou B, Gimeno-Miguel A, Lanzuela M, Prados-Torres A, Domingo L, Comas M, Sanz-Cuesta T, Del Cura-Gonzalez I, Ibañez B, Abizanda M, Duarte-Salles T, Padilla-Ruiz M, Redondo M, Castells X, Sala M; SURBCAN Group. Multimorbidity clusters among long-term breast cancer survivors in Spain: Results of the SURBCAN study. Int J Cancer. 2021 11; 149(10):1755-1767. doi:10.1002/ijc.33736. Epub 2021 Jul 17. PMID:34255861. IF: 7,396.

Khalid S, Yang C, Blacketer C, Duarte-Salles T, Fernández-Bertolín S, Kim C, Park RW, Park J, Schuemie MJ, Sena AG, Suchard MA, You SC, Rijnbeek PR, Reps JM. A standardized analytics pipeline for reliable and rapid development and validation of prediction models using observational health data. Comput Methods Programs Biomed. 2021 Nov; 211:106394. doi:10.1016/j.cmpb.2021.106394. Epub 2021 Sep 06. pmc:PMC8420135. PMID:34560604. IF: 5,428.

León-Muñoz LM, Duarte-Salles T, Llorente A, Díaz Y, Puente D, Pottegård A, Montero-Corominas D, Huerta C. Use of hydrochlorothiazide and risk of skin cancer in a large nested case-control study in Spain. Pharmacoepidemiol Drug Saf. 2021 09; 30(9):1269-1278. doi:10.1002/pds.5295. Epub 2021 Jun 08. PMID:34015159. IF: 2,890.

Li X, Lai LY, Ostropolets A, Arshad F, Tan EH, Casajust P, Alshammari TM, Duarte-Salles T, Minty EP, Areia C, Pratt N, Ryan PB, Hripcsak G, Suchard MA, Schuemie MJ, Prieto-Alhambra D. Bias, Precision and Timeliness of Historical (Background) Rate Comparison Methods for Vaccine Safety Monitoring: An Empirical Multi-Database Analysis. Front Pharmacol. 2021 ; 12:773875. doi:10.3389/fphar.2021.773875. Epub 2021 Nov 24. pmc:PMC8652333. PMID:34899334. IF: 5,810.

Li X, Ostropolets A, Makadia R, Shaoibi A, Rao G, Sena AG, Martinez-Hernandez E, Delmestri A, Verhamme K, Rijnbeek PR, Duarte-Salles T, Suchard M, Ryan P, Hripcsak G, Prieto-Alhambra D. Characterizing the incidence of adverse events of special interest for COVID-19 vaccines across eight countries: a multinational network cohort study. medRxiv. 2021 Apr; doi:10.1101/2021.03.25.21254315. Epub 2021 Apr 17. pmc:PMC8010764. PMID:33791732. IF: .

Nishimura A, Xie J, Kostka K, Duarte-Salles T, Fernández Bertolín S, Aragón M, Blacketer C, Shoaibi A, DuVall SL, Lynch K, Matheny ME, Falconer T, Morales DR, Conover MM, You SC, Pratt N, Weaver J, Sena AG, Schuemie MJ, Reps J, Reich C, Rijnbeek PR, Ryan PB, Hripcsak G, Prieto-Alhambra D, Suchard MA. Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort study. medRxiv. 2021 Mar; doi:10.1101/2021.03.18.21253778. Epub 2021 Mar 24. pmc:PMC8010772. PMID:33791740. IF: .

Pérez-Del-Pulgar C, Anguelovski I, Cole HVS, de Bont J, Connolly J, Baró F, Díaz Y, Fontán-Vela M, Duarte-Salles T, Triguero-Mas M. The relationship between residential proximity to outdoor play spaces and children's mental and behavioral health: The importance of neighborhood socio-economic characteristics. Environ Res. 2021 May; 200:111326. doi:10.1016/j.envres.2021.111326. Epub 2021 May 21. PMID:34029548. IF: 6,498.

Prats-Uribe A, Sena AG, Lai LYH, Ahmed WU, Alghoul H, Alser O, Alshammari TM, Areia C, Carter W, Casajust P, Dawoud D, Golozar A, Jonnagaddala J, Mehta PP, Gong M, Morales DR, Nyberg F, Posada JD, Recalde M, Roel E, Shah K, Shah NH, Schilling LM, Subbian V, Vizcaya D, Zhang L, Zhang Y, Zhu H, Liu L, Cho J, Lynch KE, Matheny ME, You SC, Rijnbeek PR, Hripcsak G, Lane JC, Burn E, Reich C, Suchard MA, Duarte-Salles T, Kostka K, Ryan PB, Prieto-Alhambra D. Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study. BMJ. 2021 05; 373:n1038. doi:10.1136/bmj.n1038. Epub 2021 May 11. pmc:PMC8111167. PMID:33975825. IF: 39,890.

Prieto-Alhambra D, Balló E, Coma E, Mora N, Aragón M, Prats-Uribe A, Fina F, Benítez M, Guiriguet C, Fàbregas M, Medina-Peralta M, Duarte-Salles T. Filling the gaps in the characterization of the clinical management of COVID-19: 30-day hospital admission and fatality rates in a cohort of 118?150 cases diagnosed in outpatient settings in Spain. Int J Epidemiol. 2021 01; 49(6):1930-1939. doi:10.1093/ije/dyaa190. pmc:PMC7665572. PMID:33118037. IF: 7,196.

Prieto-Alhambra D, Kostka K, Duarte-Salles T, Prats-Uribe A, Sena A, Pistillo A, Khalid S, Lai L, Golozar A, Alshammari TM, Dawoud D, Nyberg F, Wilcox A, Andryc A, Williams A, Ostropolets A, Areia C, Jung CY, Harle C, Reich C, Blacketer C, Morales D, Dorr DA, Burn E, Roel E, Tan EH, Minty E, DeFalco F, de Maeztu G, Lipori G, Alghoul H, Zhu H, Thomas J, Bian J, Park J, Roldán JM, Posada J, Banda JM, Horcajada JP, Kohler J, Shah K, Natarajan K, Lynch K, Liu L, Schilling L, Recalde M, Spotnitz M, Gong M, Matheny M, Valveny N, Weiskopf N, Shah N, Alser O, Casajust P, Park RW, Schuff R, Seager S, DuVall S, You SC, Song S, Fernández-Bertolín S, Fortin S, Magoc T, Falconer T, Subbian V, Huser V, Ahmed WU, Carter W, Guan Y, Galvan Y, He X, Rijnbeek P, Hripcsak G, Ryan P, Suchard M. Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS. Res Sq [Preprint]. 2021 Mar 1:rs.3.rs-279400. doi: 10.21203/rs.3.rs-279400/v1. PMID: 33688639; PMCID: PMC7941629. IF: .

Prieto-Alhambra D, Kostka K, Duarte-Salles T, Prats-Uribe A, Sena A, Pistillo A, Khalid S, Lai L, Golozar A, Alshammari TM, Dawoud D, Nyberg F, Wilcox A, Andryc A, Williams A, Ostropolets A, Areia C, Jung CY, Harle C, Reich C, Blacketer C, Morales D, Dorr DA, Burn E, Roel E, Tan EH, Minty E, DeFalco F, de Maeztu G, Lipori G, Alghoul H, Zhu H, Thomas J, Bian J, Park J, Roldán JM, Posada J, Banda JM, Horcajada JP, Kohler J, Shah K, Natarajan K, Lynch K, Liu L, Schilling L, Recalde M, Spotnitz M, Gong M, Matheny M, Valveny N, Weiskopf N, Shah N, Alser O, Casajust P, Park RW, Schuff R, Seager S, DuVall S, You SC, Song S, Fernández-Bertolín S, Fortin S, Magoc T, Falconer T, Subbian V, Huser V, Ahmed WU, Carter W, Guan Y, Galvan Y, He X, Rijnbeek P, Hripcsak G, Ryan P, Suchard M. Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS. Res Sq [Preprint]. 2021 Mar 1:rs.3.rs-279400. doi: 10.21203/rs.3.rs-279400/v1. PMID: 33688639; PMCID: PMC7941629. IF: .

Prieto-Alhambra D, Kostka K, Duarte-Salles T, Prats-Uribe A, Sena A, Pistillo A, Khalid S, Lai L, Golozar A, Alshammari TM, Dawoud D, Nyberg F, Wilcox A, Andryc A, Williams A, Ostropolets A, Areia C, Jung CY, Harle C, Reich C, Blacketer C, Morales D, Dorr DA, Burn E, Roel E, Tan EH, Minty E, DeFalco F, de Maeztu G, Lipori G, Alghoul H, Zhu H, Thomas J, Bian J, Park J, Roldán JM, Posada J, Banda JM, Horcajada JP, Kohler J, Shah K, Natarajan K, Lynch K, Liu L, Schilling L, Recalde M, Spotnitz M, Gong M, Matheny M, Valveny N, Weiskopf N, Shah N, Alser O, Casajust P, Park RW, Schuff R, Seager S, DuVall S, You SC, Song S, Fernández-Bertolín S, Fortin S, Magoc T, Falconer T, Subbian V, Huser V, Ahmed WU, Carter W, Guan Y, Galvan Y, He X, Rijnbeek P, Hripcsak G, Ryan P, Suchard M. Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDIS. Res Sq [Preprint]. 2021 Mar 1:rs.3.rs-279400. doi: 10.21203/rs.3.rs-279400/v1. PMID: 33688639; PMCID: PMC7941629 IF: .

Recalde M, Davila-Batista V, Díaz Y, Leitzmann M, Romieu I, Freisling H, Duarte-Salles T. Body mass index and waist circumference in relation to the risk of 26 types of cancer: a prospective cohort study of 3.5 million adults in Spain. BMC Med. 2021 Jan; 19(1):10. doi:10.1186/s12916-020-01877-3. Epub 2021 Jan 14. pmc:PMC7807518. PMID:33441148. IF: 8,775.

Recalde M, Pistillo A, Fernandez-Bertolin S, Roel E, Aragon M, Freisling H, Prieto-Alhambra D, Burn E, Duarte-Salles T. Body mass index and risk of COVID-19 diagnosis, hospitalisation, and death: a cohort study of 2 524 926 Catalans. J Clin Endocrinol Metab. 2021 Jul; doi:10.1210/clinem/dgab546. Epub 2021 Jul 23. pmc:PMC8344917. PMID:34297116. IF: 5,958.

Recalde M, Roel E, Pistillo A, Sena AG, Prats-Uribe A, Ahmed WU, Alghoul H, Alshammari TM, Alser O, Areia C, Burn E, Casajust P, Dawoud D, DuVall SL, Falconer T, Fernández-Bertolín S, Golozar A, Gong M, Lai LYH, Lane JCE, Lynch KE, Matheny ME, Mehta PP, Morales DR, Natarjan K, Nyberg F, Posada JD, Reich CG, Rijnbeek PR, Schilling LM, Shah K, Shah NH, Subbian V, Zhang L, Zhu H, Ryan P, Prieto-Alhambra D, Kostka K, Duarte-Salles T. Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom. Int J Obes (Lond). 2021 11; 45(11):2347-2357. doi:10.1038/s41366-021-00893-4. Epub 2021 Jul 15. pmc:PMC8281807. PMID:34267326. IF: 5,095.

Reps JM, Kim C, Williams RD, Markus AF, Yang C, Duarte-Salles T, Falconer T, Jonnagaddala J, Williams A, Fernández-Bertolín S, DuVall SL, Kostka K, Rao G, Shoaibi A, Ostropolets A, Spotnitz ME, Zhang L, Casajust P, Steyerberg EW, Nyberg F, Kaas-Hansen BS, Choi YH, Morales D, Liaw ST, Abrahão MTF, Areia C, Matheny ME, Lynch KE, Aragón M, Park RW, Hripcsak G, Reich CG, Suchard MA, You SC, Ryan PB, Prieto-Alhambra D, Rijnbeek PR. Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation Study. JMIR Med Inform. 2021 Apr; 9(4):e21547. doi:10.2196/21547. Epub 2021 Apr 05. pmc:PMC8023380. PMID:33661754. IF: 2,577.

Reyes C, Pistillo A, Fernández-Bertolín S, Recalde M, Roel E, Puente D, Sena AG, Blacketer C, Lai L, Alshammari TM, Ahmed WU, Alser O, Alghoul H, Areia C, Dawoud D, Prats-Uribe A, Valveny N, de Maeztu G, Sorlí Redó L, Martinez Roldan J, Lopez Montesinos I, Schilling LM, Golozar A, Reich C, Posada JD, Shah N, You SC, Lynch KE, DuVall SL, Matheny ME, Nyberg F, Ostropolets A, Hripcsak G, Rijnbeek PR, Suchard MA, Ryan P, Kostka K, Duarte-Salles T. Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study. BMJ Open. 2021 12; 11(12):e057632. doi:10.1136/bmjopen-2021-057632. Epub 2021 Dec 22. pmc:PMC8704062. PMID:34937726. IF: 2,692.

Roel E, Pistillo A, Recalde M, Fernández-Bertolín S, Aragón M, Soerjomataram I, Jenab M, Puente D, Prieto-Alhambra D, Burn E, Duarte-Salles T. Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: A population-based multistate cohort study including 4?618?377 adults in Catalonia, Spain. Int J Cancer. 2021 Oct; doi:10.1002/ijc.33846. Epub 2021 Oct 16. PMID:34655476. IF: 7,396.

Sánchez-Gómez A, Díaz Y, Duarte-Salles T, Compta Y, Martí MJ. Prediabetes, type 2 diabetes mellitus and risk of Parkinson's disease: A population-based cohort study. Parkinsonism Relat Disord. 2021 Jun; 89:22-27. doi:10.1016/j.parkreldis.2021.06.002. Epub 2021 Jun 08. PMID:34216937. IF: 4,891.

Tan EH, Sena AG, Prats-Uribe A, You SC, Ahmed WU, Kostka K, Reich C, Duvall SL, Lynch KE, Matheny ME, Duarte-Salles T, Bertolin SF, Hripcsak G, Natarajan K, Falconer T, Spotnitz M, Ostropolets A, Blacketer C, Alshammari TM, Alghoul H, Alser O, Lane JCE, Dawoud DM, Shah K, Yang Y, Zhang L, Areia C, Golozar A, Recalde M, Casajust P, Jonnagaddala J, Subbian V, Vizcaya D, Lai LYH, Nyberg F, Morales DR, Posada JD, Shah NH, Gong M, Vivekanantham A, Abend A, Minty EP, Suchard M, Rijnbeek P, Ryan PB, Prieto-Alhambra D. COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. Rheumatology (Oxford). 2021 10; 60(SI):SI37-SI50. doi:10.1093/rheumatology/keab250. pmc:PMC7989171. PMID:33725121. IF: 7,580.

Troncoso-Mariño A, Roso-Llorach A, López-Jiménez T, Villen N, Amado-Guirado E, Fernández-Bertolin S, Carrasco-Ribelles LA, Borras JM, Violán C. Medication-Related Problems in Older People with Multimorbidity in Catalonia: A Real-World Data Study with 5 Years' Follow-Up. J Clin Med. 2021 Feb; 10(4). doi:10.3390/jcm10040709. Epub 2021 Feb 11. pmc:PMC7916946. PMID:33670201. IF: 3,303.

Turkiewicz A, Díaz Y, Duarte-Salles T, Prieto-Alhambra D. Knee and hip osteoarthritis and risk of nine cancers in a large real-world matched cohort study. Rheumatology (Oxford). 2021 Oct; doi:10.1093/rheumatology/keab733. Epub 2021 Oct 02. PMID:34599812. IF: 7,580.

Zamora-Sánchez JJ, Zabaleta-Del-Olmo E, Fernández-Bertolín S, Gea-Caballero V, Julián-Rochina I, Pérez-Tortajada G, Amblàs-Novellas J. Profiles of Frailty among Older People Users of a Home-Based Primary Care Service in an Urban Area of Barcelona (Spain): An Observational Study and Cluster Analysis. J Clin Med. 2021 May; 10(10). doi:10.3390/jcm10102106. Epub 2021 May 13. pmc:PMC8153285. PMID:34068296. IF: 3,303.

Indicators

Indicator

2021

Researchers with PhD

3

Total number of projects in which group members have participated

40

Total number of projects in which the PI of the project has belonged to the group

27

Total Funding

2.225.297,34€

Scientific publications in indexed journals

24

Total Impact factor

254,83

Nº of articles in Q1 journals

17

Q1 IF

229,87

Nº of articles in Q2 journals

4

Q2 IF

15,772

Anar a l'inici